Defective apoptosis as potential mechanism in the tumorogenesis of myelolipoma

European Journal of Histochemistry

Volumn 43, Issue 1, 1999, Pages 15-18

  Cappello, F ^a   Farina, F ^a   Di Felice, V ^a   Marciano V ^a   Todaro, M ^a   Balsano, G ^a   Zummo, G ^a   Stassi, G ^a  

^a NONE

Author keywords

Apoptosis; Bone marrow; Choristoma; Fas; Myelolipoma

Indexed keywords

CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; FAS ANTIGEN; LEUKOCYTE ANTIGEN;

ADRENAL TUMOR; APOPTOSIS; ARTICLE; BIOSYNTHESIS; BONE MARROW CELL; CYTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MYELOLIPOMA; NICK END LABELING; PATHOLOGY;

ADRENAL GLAND NEOPLASMS; ANTIGENS, CD; ANTIGENS, CD95; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; APOPTOSIS; BONE MARROW CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MYELOLIPOMA;

EID: 0033404862     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Damjanov I., Moriber Katz S., Catalano E., Mason D., and Schwartz A.B.: Myelolipoma in a heterotopic adrenal gland. Cancer 44, 1350, 1979.
2. DeBlois G.G., and DeMay R.M.: Adrenal Myelolipoma diagnosed by computer tomography-guided fine needle aspiration. Cancer 55, 848, 1982.
3. Giordano C., Stassi G., De Maria R., Todaro M., Richiusa P., Papoff G., Ruberti G., Bagnasco M., Testi R., and Galluzzo A.: Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275, 960; 1997.
4. Gould J.D., Mitty H.A., Pertsemlidis D., and Szporn A.H.: Adrenal myelolipoma: diagnosis of fine needle aspiration. Am. J. Radiol. 148, 921, 1987.
5. + T cells from human immunodeficiency virus infected asymptomatic individuals. J. Exp. Med. 175, 331, 1992.
6. Krammer P.H., Dhein J., Walczak H., Berhmann I., Mariani S., Matiba M., Daniel P., Knipping E., Westemdorp M.O., Striker K., Baumler C., Heebardt S., Germer M., Peter M.E., and Debatin K.M.: The role of APO-1-mediated apoptosis in the immune system. Immunol. Rev. 142, 175, 1994.
7. Massey G.S., Green J.B., and Marsh W.L. Jr.: Presacral myelolipoma. Cancer 60, 403, 1987.
8. Mattson M.P., Cheng B., Davis D., Bryant K., Leibenburg I., and Rydel R.E.: Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excilotoxicity. J. Neuroscience 12, 376, 1992.
9. Nagata S., and Golstein P.: The Fas death factor. Science 267, 1449, 1995.
10. Oliva A., Duarte B., Hammadeh R., Ghosh L., and Baker R.J.: Myelolipoma and endocrine dysfunction. Surgery 103, 6-711, 1988.
11. Oren M.: The involvement of oncogenes and tumor suppressor genes in the control of apoptosis. Cancer Metastasis Rev. 11, 141, 1990.
12. Stassi G., Todaro M., De Maria R., Candore G., Cigna D., Caruso C., Galluzzo A., and Giordano C.: Defective expression of CD95 (FAS/APO-1) molecule suggests apoptosis impairment of T and B cells in HLA-B8, DR3-positive individuals. Human Immunology 55, 39, 1997a.
13. Stassi G., De Maria R., Rudert W., Testi R., Galluzzo A., Giordano C., and Trucco M: Nitric oxide primes pancreatic b-cells for Fas-mediated destruction in Insulin-dependent Diabetes Mellitus. J. Exp. Med. 186, 1193, 1997b.
14. Umpierrez M.B., Fackler S., Umpierrez G.E., and Rubin J.: Adrenal myelolipoma associated with endocrine dysfunction: review of the literature. Am. J. Med. Sci. 314, 5-338, 1997.
15. Watanabe-Fukunaga R., Brannon C.I., Copeland N.G., Jenkins N.A., and Nagata S.: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314, 1992.
16. Yang G.C.H., Coleman B., Daly J.M., and Gupta P.K.: Presacral myelolipoma: Report of a case with fine needle aspiration cytology and immunohistochemical and histochemical studies. Acta Cytol. 36, 6-932, 1992.